Hall W, Darke S, Ross M, Wodak A
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Addiction. 1993 Apr;88(4):509-16. doi: 10.1111/j.1360-0443.1993.tb02057.x.
Data are presented on the patterns of drug use and HIV risk-taking of daily amphetamine and opioid injectors among 1245 injecting drug users who were interviewed in Sydney in 1989. About one-third of the sample had injected amphetamines during a typical month of injecting, and 12% were using amphetamines on a daily basis. Daily amphetamine injectors were younger, less well educated, and less likely to have engaged in drug treatment, but they were no more likely than daily opioid users to have shared injection equipment or to have engaged in other behaviour likely to transmit HIV. Although there seemed to be no special cause for concern about HIV risk-taking among amphetamine injectors, there was nonetheless a high prevalence of sharing injecting equipment, with over half of daily amphetamine and heroin injectors having shared in the past several months. In addition, approximately a third of amphetamine injectors were injecting on a daily basis, a pattern of use which increases the risk of developing a severe dependence syndrome, and of experiencing an amphetamine-induced psychosis.
本文呈现了1989年在悉尼接受访谈的1245名注射吸毒者中，每日使用苯丙胺和阿片类药物注射者的用药模式及感染艾滋病毒的风险行为。约三分之一的样本在典型的注射月份中注射过苯丙胺，12%的人每日使用苯丙胺。每日注射苯丙胺者较为年轻，受教育程度较低，接受药物治疗的可能性较小，但与每日使用阿片类药物者相比，他们共用注射器具或从事其他可能传播艾滋病毒行为的可能性并无差异。虽然似乎没有特别理由担心苯丙胺注射者的艾滋病毒感染风险行为，但共用注射器具的情况仍然很普遍，超过一半的每日注射苯丙胺和海洛因者在过去几个月中曾有过共用行为。此外，约三分之一的苯丙胺注射者每日注射，这种用药模式会增加出现严重依赖综合征以及患苯丙胺所致精神病的风险。
